9 reports

More than one percent of the world' s population is affected by bipolar disorder.

  • Cancer
  • Hepatitis
  • Sweden
  • Karolinska Institutet Holding
  • Takeda Pharmaceutical Company Limited
  • LICENSING AGREEMENTS

It also offers treatments for acid reflux disease, infectious diseases, bipolar I disorder, schizophrenia, alzheimer' s disease, epilepsy, migraine prevention and treatment.

  • Hepatitis
  • Pharmaceutical
  • Therapy
  • United States
  • Corporate Finance

It also offers treatments for acid reflux disease, infectious diseases, bipolar I disorder, schizophrenia, alzheimer' s disease, epilepsy, migraine prevention and treatment.

  • Healthcare
  • Hepatitis
  • Pharmaceutical
  • Sweden
  • Medivir UK Ltd.

It also offers treatments for acid reflux disease, infectious diseases, bipolar I disorder, schizophrenia, alzheimer' s disease, epilepsy, migraine prevention and treatment.

  • Hepatitis
  • Medical Biotechnology
  • United States
  • Company
  • Bristol-Myers Squibb Company

It also offers treatments for acid reflux disease, infectious diseases, bipolar I disorder, schizophrenia, alzheimer' s disease, epilepsy, migraine prevention and treatment.

  • Hepatitis
  • Medical Biotechnology
  • United States
  • Company
  • Bristol-Myers Squibb Company

Mechanism of Action Johnson & Johnson is developing JNJ-## for the treatment of bipolar disorder.

  • Hepatitis
  • Monoclonal Antibody
  • Targeted Therapy
  • Therapy
  • United States

Bifeprunox was under development for the treatment of schizophrenia and bipolar disorder.

  • Digestive System Disorder
  • Hepatitis
  • Therapy
  • United States
  • AbbVie Inc.
  • LEUKEMIA, RELAPSED ACUTE MYELOID LEUKEMIA

Key Therapeutic Areas Cardiovascular Central Nervous System Dermatology Ear Nose Throat Disorders Gastrointestinal Genetic Disorders Genito Urinary System And Sex Hormones Hematological Disorders Immunology Infectious Disease Metabolic Disorders Musculoskeletal

  • Cancer
  • Hepatitis
  • Monoclonal Antibody
  • Therapy
  • United States

The drug candidate was under development for the treatment of bipolar disorder (manic depression) and general anxiety disorder.

  • Cancer
  • Hepatitis
  • Targeted Therapy
  • Therapy
  • Novartis AG